Page last updated: 2024-11-02
phenazopyridine and Bladder, Overactive
phenazopyridine has been researched along with Bladder, Overactive in 1 studies
Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
Research Excerpts
Excerpt | Relevance | Reference |
"To compare pain scores with preprocedure oral phenazopyridine vs intravesical lidocaine in women undergoing intradetrusor onabotulinumtoxinA injections for idiopathic overactive bladder." | 5.51 | Oral phenazopyridine vs intravesical lidocaine for bladder onabotulinumtoxinA analgesia: a randomized controlled trial. ( Jacobs, KM; Raker, CA; Siddique, M; Stewart, LE; Sung, VW, 2022) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
Stewart, LE | 1 |
Siddique, M | 1 |
Jacobs, KM | 1 |
Raker, CA | 1 |
Sung, VW | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Oral Phenazopyridine Versus Intravesical Lidocaine for Office OnabotulinumtoxinA Analgesia: A Randomized Controlled Trial[NCT03755089] | Phase 4 | 110 participants (Anticipated) | Interventional | 2018-11-01 | Recruiting |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for phenazopyridine and Bladder, Overactive